Kompier, L. C., Lurkin, I., van der Aa, M. N. M., van Rhijn, B. W. G., van der Kwast, T. H., & Zwarthoff, E. C. (2010). FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy. Public Library of Science.
Citación estilo ChicagoKompier, Lucie C., Irene Lurkin, Madelon N. M. van der Aa, Bas W. G. van Rhijn, Theo H. van der Kwast, and Ellen C. Zwarthoff. FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential As Biomarkers for Surveillance and Therapy. Public Library of Science, 2010.
Cita MLAKompier, Lucie C., et al. FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential As Biomarkers for Surveillance and Therapy. Public Library of Science, 2010.